Salgia R - Search Results

1

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.

Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR, Turkyilmaz MA, Salgia R, Yamada SD, Vande Woude GF, Tretiakova MS, Lengyel E. Sawada K, et al. Among authors: salgia r. Cancer Res. 2007 Feb 15;67(4):1670-9. doi: 10.1158/0008-5472.CAN-06-1147. Cancer Res. 2007. PMID: 17308108

2

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R. Maulik G, et al. Among authors: salgia r. Clin Cancer Res. 2002 Feb;8(2):620-7. Clin Cancer Res. 2002. PMID: 11839685

3

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Among authors: salgia r. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

4

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R. Kijima T, et al. Among authors: salgia r. Cancer Res. 2002 Nov 1;62(21):6304-11. Cancer Res. 2002. PMID: 12414661

5

c-Met: structure, functions and potential for therapeutic inhibition.

Ma PC, Maulik G, Christensen J, Salgia R. Ma PC, et al. Among authors: salgia r. Cancer Metastasis Rev. 2003 Dec;22(4):309-25. doi: 10.1023/a:1023768811842. Cancer Metastasis Rev. 2003. PMID: 12884908 Review.

6

A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

Sattler M, Pride YB, Ma P, Gramlich JL, Chu SC, Quinnan LA, Shirazian S, Liang C, Podar K, Christensen JG, Salgia R. Sattler M, et al. Among authors: salgia r. Cancer Res. 2003 Sep 1;63(17):5462-9. Cancer Res. 2003. PMID: 14500382

7

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R. Ma PC, et al. Among authors: salgia r. Cancer Res. 2003 Oct 1;63(19):6272-81. Cancer Res. 2003. PMID: 14559814

8

Therapeutic targeting of the receptor tyrosine kinase Met.

Sattler M, Ma PC, Salgia R. Sattler M, et al. Among authors: salgia r. Cancer Treat Res. 2004;119:121-38. doi: 10.1007/1-4020-7847-1_7. Cancer Treat Res. 2004. PMID: 15164876 Review. No abstract available.

9

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K, Lader A, Richards W, Sugarbaker D, Husain AN, Christensen JG, Salgia R. Ma PC, et al. Among authors: salgia r. Cancer Res. 2005 Feb 15;65(4):1479-88. doi: 10.1158/0008-5472.CAN-04-2650. Cancer Res. 2005. PMID: 15735036

10

A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.

Ma PC, Schaefer E, Christensen JG, Salgia R. Ma PC, et al. Among authors: salgia r. Clin Cancer Res. 2005 Mar 15;11(6):2312-9. doi: 10.1158/1078-0432.CCR-04-1708. Clin Cancer Res. 2005. PMID: 15788682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters